Truqap 160mg and 200mg Film-Coated Tablets
*Company:
AstraZeneca Pharmaceuticals (Ireland) DACStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 30 July 2026
File name
20260312 SPC IE MT Truqap tablets 160mg 200mg CAPItello-291 OS FA ONC 26 0008.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Initial Marketing Authorisation
Updated on 30 July 2026
File name
20250724 Package leaflet IE MT Truqap Tablets 160mg 200mg Addition of ADR ONC 25 0027.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
Initial Marketing Authorisation
AstraZeneca Pharmaceuticals (Ireland) DAC
 DAC.webp)
Address:
College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925Medical Information E-mail:
mipqc.ireland@astrazeneca.comTelephone:
+353 1 609 7100Fax:
+353 1 686 5038Website:
https://contactazmedical.astrazeneca.comMedical Information Direct Line:
1800 800 899